We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Daktronics
DAKT
$941M
| $1.44M | 0.02% |
121,021
-11,700
| -9% | -$152K |
|
452
Viavi Solutions
VIAV
$9.75B
| $1.43M | 0.02% |
201,467
-964,527
| -83% | -$6.56M |
|
453
Cathay General Bancorp
CATY
$4.2B
| $1.42M | 0.02% |
55,460
-89,853
| -62% | -$2.21M |
|
|
LIOX
454
DELISTED
Lionbridge Technologies
LIOX
| $1.4M | 0.02% |
235,463
+83,443
| +55% | +$489K |
|
455
Federal Realty Investment Trust
FRT
$10.9B
| $1.4M | 0.02% |
11,560
-5,370
| -32% | -$634K |
|
456
American States Water
AWR
$3.39B
| $1.4M | 0.02% |
41,987
-52,920
| -56% | -$1.62M |
|
|
NOR
457
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $1.39M | 0.02% |
56,216
-12,343
| -18% | -$308K |
|
|
KEG
458
DELISTED
KEY ENERGY SERVICES INC
KEG
| $1.38M | 0.02% |
+151,000
| New | +$1.38M |
|
459
AbbVie
ABBV
$458B
| $1.37M | 0.02% |
24,200
-80,950
| -77% | -$4.25M |
|
460
First Interstate BancSystem
FIBK
$3.7B
| $1.36M | 0.02% |
50,050
+15,720
| +46% | +$412K |
|
461
AMERISAFE
AMSF
$569M
| $1.36M | 0.02% |
33,406
-3,400
| -9% | -$135K |
|
462
Meta Platforms (Facebook)
META
$1.51T
| $1.36M | 0.02% |
+20,180
| New | +$1.24M |
|
463
NVR
NVR
$17.2B
| $1.33M | 0.02% |
1,155
-62
| -5% | -$69.2K |
|
|
CBK
464
DELISTED
Christopher & Banks Corporation
CBK
| $1.33M | 0.02% |
151,700
-22,300
| -13% | -$154K |
|
|
DMC
465
Del Monte Corp
DMC
$1.35B
| $1.32M | 0.02% |
42,923
-500
| -1% | -$14.2K |
|
466
Build-A-Bear
BBW
$423M
| $1.3M | 0.02% |
97,330
+74,796
| +332% | +$976K |
|
|
TEN
467
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.29M | 0.02% |
19,718
-16,500
| -46% | -$1.02M |
|
468
Boise Cascade
BCC
$2.74B
| $1.29M | 0.02% |
44,910
-14,200
| -24% | -$379K |
|
|
PAY
469
DELISTED
Verifone Systems Inc
PAY
| $1.28M | 0.02% |
+34,890
| New | +$1.19M |
|
|
ALR
470
DELISTED
Alere Inc
ALR
| $1.25M | 0.02% |
+33,524
| New | +$1.19M |
|
471
Rigel Pharmaceuticals
RIGL
$680M
| $1.25M | 0.02% |
34,345
-2,714
| -7% | -$92.3K |
|
472
IDT Corp
IDT
$1.6B
| $1.25M | 0.02% |
101,315
+16,568
| +20% | +$192K |
|
473
Service Corp International
SCI
$11.4B
| $1.24M | 0.02% |
59,900
-52,642
| -47% | -$1.03M |
|
474
PNC Financial Services
PNC
$100B
| $1.24M | 0.02% |
13,900
-8,120
| -37% | -$693K |
|
475
Enovis
ENOV
$1.56B
| $1.22M | 0.02% |
9,505
-1,482
| -13% | -$185K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.